We hypothesize that telomere length is not a simple mitotic counter but a sensor of informational entropy that directly modulates osteoblast endocrine output via shelterin‑dependent chromatin states at the osteocalcin (Ocn) promoter. Oxidative stress–induced telomere damage triggers K+ ion quantum tunneling through G‑quadruplex structures, destabilizing shelterin and altering nucleosome positioning at nearby gene loci. This structural signal reduces Ocn transcription, lowering circulating osteocalcin and thereby impairing its downstream effects on glucose homeostasis, male fertility, and brain function. Consequently, aging‑associated telomere entropy accumulation drives systemic decline independently of cell‑division count, and rescuing telomere structure—without lengthening repeats—should restore osteocalcin secretion and mitigate age‑related metabolic dysfunction.

Mechanistic rationale Chronic psychosocial stress elevates ROS and glucocorticoids, which oxidize telomeric guanines to 8‑oxoG, weakening shelterin binding [1]. Oxidized telomeres also increase the probability of K+ ions tunneling through G‑quadruplexes on picosecond timescales, a process predicted by Schrödinger‑derived entropic tunneling times [3]. Tunnel‑induced K+ flux destabilizes the G‑quadruplex, promoting shelterin dissociation and exposing the telomere end to a DNA damage response that can remodel local chromatin even when repeat length remains above the senescence threshold [1]. We propose that this chromatin remodeling spreads in cis to the Ocn promoter, which resides in a subtelomeric region prone to position‑effect variegation. Loss of shelterin-mediated heterochromatin leads to increased nucleosome occupancy and reduced RNA polymerase II recruitment, decreasing Ocn mRNA synthesis.

Testable predictions

1. Osteoblasts exposed to low‑dose H2O2 or corticosterone will show increased telomeric 8‑oxoG, reduced shelterin (TRF2) occupancy, and heightened K+‑dependent G‑quadruplex destabilization, accompanied by decreased Ocn promoter accessibility (ATAC‑seq) and lower secreted osteocalcin, without a significant change in average telomere length measured by qPCR.
2. CRISPR‑mediated overexpression of TRF2 or a telomere‑targeted antioxidant (e.g., mitochondrially targeted catalase fused to a telomere‑binding domain) will rescue shelterin binding and Ocn expression under oxidative stress, despite persistent ROS.
3. Mice with osteoblast‑specific deletion of the shelterin component TIN2 will exhibit low circulating osteocalcin, glucose intolerance, and cognitive deficits that are not ameliorated by telomerase activation (TERT overexpression) but are reversed by osteocalcin replacement therapy.
4. Pharmacological stabilization of telomeric G‑quadruplexes using small‑molecule ligands (e.g., pyridostatin) will attenuate stress‑induced Ocn suppression, linking ion tunneling dynamics to transcriptional output.

Experimental approach

• Primary mouse osteoblasts cultured with physiological H2O2 (50 µM) or corticosterone (100 nM) for 24 h; assess 8‑oxoG via dot‑blot, shelterin ChIP‑qPCR, K+‑sensitive fluorophore trapping in G‑quadruplexes, ATAC‑seq at the Ocn locus, and osteocalcin ELISA.
• Generate osteoblast‑specific TRF2‑overexpressing mice; subject to chronic variable stress and monitor glucose tolerance tests, insulin sensitivity, and hippocampal‑dependent memory.
• Cross TIN2‑fl/fl mice with Osx‑Cre lines; treat cohorts with telomerase activator (TA‑65) versus recombinant osteocalcin; compare metabolic and cognitive phenotypes.
• Treat stressed osteoblasts with pyridostatin (1 µM) and measure Ocn rescue; verify G‑quadruplex stabilization by CD spectroscopy.

Falsifiability If oxidative stress reduces Ocn secretion solely through telomere shortening, then telomerase activation should fully restore osteocalcin levels regardless of shelterin status. Conversely, if osteocalcin remains low despite telomere lengthening but recovers with shelterin reinforcement or G‑quadruplex stabilization, the hypothesis is supported. Similarly, if TIN2 loss does not affect Ocn expression, the proposed chromatin‑mediated mechanism would be refuted. This framework directly links telomeric entropy sensing to bone‑derived endocrine regulation of aging, offering a tractable, falsifiable path forward.